Notice this line from the post.
I think it's the intended punchline.
Yes, he does appear to be contradicting a few too many people on that. We should be hearing something from New York about it anytime now. Hope they didn’t switch out the drug for a placebo!
Ah, good catch.
Plaquenil which has weak ACE2 blockade doesn't appear to be a savior of any kind in our patient population. Theoretically, it may have some prophylactic properties but so far it is difficult to see the benefit to our hospitalized patients, but we are using it and the studies will tell. With Plaquenil's potential QT prolongation and liver toxic effects (both particularly problematic in covid 19 patients), I am not longer selectively prescribing this medication as I stated on a previous post.We are also using Azithromycin...
Several drugs have been withdrawn from the U.S. market or have received black box warnings due to their potential to cause QT interval prolongation that leads to fatal ventricular arrhythmias and sudden cardiac death.